Approvals/TGA/HERZUMA trastuzumab (rch) 440 mg powder for injection for intravenous infusion vial with diluent

Approved

STANDARD

HERZUMA trastuzumab (rch) 440 mg powder for injection for intravenous infusion vial with diluent

Celltrion Healthcare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4eee56bf2a0449d4
Product Name: HERZUMA trastuzumab (rch) 440 mg powder for injection for intravenous infusion vial with diluent
Artg Id: 318115
Artg Name: HERZUMA trastuzumab (rch) 440 mg powder for injection for intravenous infusion vial with diluent
Sponsor: Celltrion Healthcare Australia Pty Ltd
Company Detail Path: /organization/celltrion-healthcare-australia-pty-ltd
Artg Date: 2020-04-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-02184-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01298-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4eee56bf2a0449d4

Type

Standard